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Purpose: To review the pathogenesis, diagnosis, presentation, diagno-
sis, management and outcomes (morbidity and mortality) of superficial
femoral artery aneurysms.
Methods: A comprehensive review of this entity was performed based
on the available literature in all languages and a detailed discussion of our
findings is also provided.
Results: Our review identified 61 cases of SFA aneurysms. They
were most often seen in elderly men, predominately affected the right
lower extremity, and were most often located in the middle-third of the
artery. At the time of diagnosis, SFA aneurysms were frequently symp-
tomatic because they reached a relative large diameter before the diag-
nosis was made. The most frequent presentation was localized pain in
association with a pulsatile mass. In contrast to popliteal aneurysms, SFA
aneurysms more frequently present with rupture than distal ischemia.
Angiography was by far the most commonly utilized diagnostic tool.
Treatment was primarily by means of an interposition graft, followed by
exclusion and surgical bypass. Endovascular repair of SFA aneurysms has
only been reported in three instances. SFA aneurysm repair was most
often associated with favorable outcomes, with low reported rates of
ischemia and limb loss.
Efficacy of Viabahn® in the Treatment of Severe Superficial Femoral
Artery Lesions: Which Factors Influence Long-term Patency?
Alimi Y.S., Hakam Z., Hartung O., Boufi M., Barthèlemy P., Aissi K.,
Dubuc M. Eur J Vasc Endovasc Surg 2007;xx:xx-xx.
Purpose: To evaluate superficial femoral artery (SFA) occlusive disease
treatment by means of covered stents.
Study design: retrospective.
Method: From 2000 to 2005, a Hemobahn/Viabahn® endoprosthesis
was implanted in 102 limbs (95 patients; mean age: 72.1 years, 52–94) for
intermittent claudication (group I, n  50 limbs), critical (group II,
n  32) or acute ischemia (group III, n  20). Lesions treated were Trans-
Atlantic Inter-Society Consensus (TASC) A (n  9) B (n  42), C
(n  28) or D (n  23), associated with a good (2 or 3 leg arteries, n  60)
or a poor (1 or 0 artery, n  42) runoff.
Results: The endograft was placed successfully in all cases, but 3 early
deaths (3.2%) (1 in group II and 2 in group III), and 4 acute thromboses
(4%) occurred. Primary and secondary actuarial patency rates were
97  1.7%, and 99  1% at 1 month, 74  4.8% & 84  4.1% at 1 year,and
71  9.5% & 79  8.5% at 3 years, after a mean follow-up of 30.2 months
(1–60). Long-term primary and secondary patencies were significantly
different between TASC Cand TASC D lesions (P  .004 & .001).
Conclusion: Severity of lesions, rather than preoperative symptoms or
runoff, is mainly to be considered before using Hemobahn/Viabahn®
endoprosthesis in severe SFA occlusive lesions.
Compression Therapy for Occupational Leg Symptoms and Chronic
Venous Disorders – a Meta-analysis of Randomised Controlled Trials
Amsler F., Blättler W. Eur J Vasc Endovasc Surg 2007;xx:xx-xx.
Objective: Leg discomfort and oedema are commonly attributed to a
venous disorder (CVD) or chronic venous insufficiency (CVI) and treated
with compression hosiery. The pressure needed to achieve clinical benefit is
a matter of debate.
Design: We performed a meta-analysis of randomised controlled trials
(RCT) that compared stockings exerting an ankle pressure of 10–20 mmHg
with placebo or no treatment and with stockings exerting a pressure of more
than 20 mmHg.
Methods: RCT were retrieved and analysed with the tools of the
Cochrane Collaboration. Each study was reviewed independently. Subjec-
tive dichotomous and continuous factors and objective findings were pooled
for statistical treatment.
Results: Eleven RCT fulfilled the predefined criteria. They included
1453 randomised subjects, 794 healthy people exposed to various forms of
stress, 552 patients with a chronic venous disorder or chronic venous
insufficiency and 141 patients after varicose vein surgery. Over all, compres-
sion with 10–20 mmHg had a clear effect on oedema and symptoms as
compared with 10 mmHg pressure, placebo stockings, or no treatment
(p  .0001). No study showed a difference between 10–20 and
20 mmHg stockings.
Conclusions: Despite important methodological heterogeneity and
sometimes sub-standard reporting the meta-analysis suggests that leg com-
pression with 10–15 mmHg is an effective treatment for CVD. Less pressure
is ineffective and higher pressure may be of no additional benefit.
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